awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35833312-27E26D5F-41D1-4D2B-9772-6E0EEABC4B8C
Q35833312-27E26D5F-41D1-4D2B-9772-6E0EEABC4B8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35833312-27E26D5F-41D1-4D2B-9772-6E0EEABC4B8C
Efficacy of Rituximab in Refractory Inflammatory Myopathies Associated with Anti- Synthetase Auto-Antibodies: An Open-Label, Phase II Trial
P2860
Q35833312-27E26D5F-41D1-4D2B-9772-6E0EEABC4B8C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35833312-27E26D5F-41D1-4D2B-9772-6E0EEABC4B8C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a1ac720d4594a9deb941d31763ff148ffce4960d
P2860
Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.